This study aims at quantifying the accuracy of a self-administered fingerstick based glucose tolerance test (GTT@Home) respect to the gold-standard in-clinic venous plasma measures during the oral glucose tolerance test (OGTT) across a wide range of glycemic values in people at risk for clinical type 1 diabetes (T1D) (carriers of at least one islet autoantibody) or with new onset Stage 3 T1D within 100 days from the diagnosis.
Investigators will conduct an observational longitudinal study that will include one home-based unsupervised GTT@Home test, a standard OGTT at a research facility and a supervised GTT@Home. Additionally, participants will have up to10-day blinded-CGM data collected.
Study Type
OBSERVATIONAL
Enrollment
60
self-administered fingerstick based glucose tolerance test
Yale University Pediatric and Adult Diabetes Clinic
New Haven, Connecticut, United States
RECRUITINGAccuracy of GTT@Home
The accuracy will be quantified by correlation between GTT@Home and OGTT glucose measures as well as by the mean absolute relative difference between the two measures.
Time frame: up to 4 weeks from enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.